BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir Read more
Remdesivir, tocilizumab being considered for ‘restricted use’ on severely ill COVID-19 patients Read more
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage: GlobalData Read more